BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8229500)

  • 1. Copper-histidine therapy for Menkes disease.
    Sarkar B; Lingertat-Walsh K; Clarke JT
    J Pediatr; 1993 Nov; 123(5):828-30. PubMed ID: 8229500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations and clinical outcomes of copper-histidine therapy in Menkes disease patients.
    Kim JH; Lee BH; Kim YM; Choi JH; Kim GH; Cheon CK; Yoo HW
    Metab Brain Dis; 2015 Feb; 30(1):75-81. PubMed ID: 24919650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menkes' kinky hair syndrome.
    George S; Matthai SA; Sosamma MM; Sukumaran TU
    Indian J Pediatr; 2005 Oct; 72(10):891-2. PubMed ID: 16272669
    [No Abstract]   [Full Text] [Related]  

  • 4. Copper-histidine treatment of Menkes disease.
    Garnica A; Chan WY; Rennert O
    J Pediatr; 1994 Aug; 125(2):336-8. PubMed ID: 8093166
    [No Abstract]   [Full Text] [Related]  

  • 5. Menkes' disease: report of a case and determination of eumelanin and pheomelanin in hypopigmented hair.
    Tomita Y; Kondo Y; Ito S; Hara M; Yoshimura T; Igarashi H; Tagami H
    Dermatology; 1992; 185(1):66-8. PubMed ID: 1638075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients.
    Christodoulou J; Danks DM; Sarkar B; Baerlocher KE; Casey R; Horn N; Tümer Z; Clarke JT
    Am J Med Genet; 1998 Mar; 76(2):154-64. PubMed ID: 9511979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In utero copper treatment for Menkes disease associated with a severe ATP7A mutation.
    Haddad MR; Macri CJ; Holmes CS; Goldstein DS; Jacobson BE; Centeno JA; Popek EJ; Gahl WA; Kaler SG
    Mol Genet Metab; 2012 Sep; 107(1-2):222-8. PubMed ID: 22695177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menkes' disease: long-term treatment with copper and D-penicillamine.
    Nadal D; Baerlocher K
    Eur J Pediatr; 1988 Aug; 147(6):621-5. PubMed ID: 3181204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative abnormalities in Menkes disease.
    Rizzo C; Bertini E; Piemonte F; Leuzzi V; Sabetta G; Federici G; Luchetti A; Dionisi-Vici C
    J Inherit Metab Dis; 2000 Jun; 23(4):349-51. PubMed ID: 10896291
    [No Abstract]   [Full Text] [Related]  

  • 10. [Manufacturing and stability of copper-histidine solution for treatment of Menkes' Kinky Hair Syndrome].
    Hoppe-Tichy T; Nguyen TH; Hentze BW; Lorke M
    Pharmazie; 2005 Mar; 60(3):205-7. PubMed ID: 15801674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infantile spasms and Menkes disease.
    Sfaello I; Castelnau P; Blanc N; Ogier H; Evrard P; Arzimanoglou A
    Epileptic Disord; 2000 Dec; 2(4):227-30. PubMed ID: 11174154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper concentration of liver tissue under long-term copper-histidine therapy in a patient with Menkes disease.
    Kroepfl T; Mair E; Deutsch J; Brunner-Krainz M; Paschke E; Plecko B
    J Inherit Metab Dis; 2006 Aug; 29(4):593. PubMed ID: 16786254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menkes kinky hair syndrome: Is it a treatable disorder?
    Garnica AD; Frias JL; Rennert OM
    Clin Genet; 1977 Feb; 11(2):154-61. PubMed ID: 189959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of copper-histidine therapy on brain metabolism in a patient with Menkes disease: a proton magnetic resonance spectroscopic study.
    Munakata M; Sakamoto O; Kitamura T; Ishitobi M; Yokoyama H; Haginoya K; Togashi N; Tamura H; Higano S; Takahashi S; Ohura T; Kobayashi Y; Onuma A; Iinuma K
    Brain Dev; 2005 Jun; 27(4):297-300. PubMed ID: 15862194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menkes disease after copper histidine replacement therapy: case report.
    George DH; Casey RE
    Pediatr Dev Pathol; 2001; 4(3):281-8. PubMed ID: 11370266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menkes disease mutations and response to early copper histidine treatment.
    Kaler SG
    Nat Genet; 1996 May; 13(1):21-2. PubMed ID: 8673098
    [No Abstract]   [Full Text] [Related]  

  • 17. [Menkes' disease: heterozygosity testing by quantitative real-time PCR and the dilemma of therapeutic support].
    Rittinger O; Sander G; Schaller A; Gallati S; Mayr H; Sperl W
    Klin Padiatr; 2005; 217(5):286-90. PubMed ID: 16167277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early copper therapy in classic Menkes disease patients with a novel splicing mutation.
    Kaler SG; Buist NR; Holmes CS; Goldstein DS; Miller RC; Gahl WA
    Ann Neurol; 1995 Dec; 38(6):921-8. PubMed ID: 8526465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper histidinate therapy in Menkes' disease: prevention of progressive neurodegeneration.
    Sherwood G; Sarkar B; Kortsak AS
    J Inherit Metab Dis; 1989; 12 Suppl 2():393-6. PubMed ID: 2512453
    [No Abstract]   [Full Text] [Related]  

  • 20. Menkes disease: importance of diagnosis with molecular analysis in the neonatal period.
    Costa LS; Pegler SP; Lellis RF; Krebs VL; Robertson S; Morgan T; Honjo RS; Bertola DR; Kim CA
    Rev Assoc Med Bras (1992); 2015; 61(5):407-10. PubMed ID: 26603002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.